Format

Send to

Choose Destination
Clin Mol Hepatol. 2019 Jun;25(2):199-209. doi: 10.3350/cmh.2018.0084. Epub 2019 Mar 11.

Effects of zolpidem on sleep parameters in patients with cirrhosis and sleep disturbances: A randomized, placebo-controlled trial.

Author information

1
Department of Hepatology and Liver Transplantation, Institute of Liver and Biliary Sciences, New Delhi, India.
2
Department of Pulmonary Medicine, Institute of Liver and Biliary Sciences, New Delhi, India.
3
Department of Clinical Research, Institute of Liver and Biliary Sciences, New Delhi, India.
4
Department of Neurology, Institute of Liver and Biliary Sciences, New Delhi, India.
5
Department of Biostatistics, Institute of Liver and Biliary Sciences, New Delhi, India.

Abstract

BACKGROUND/AIMS:

The aim of this study was to study the efficacy and safety of zolpidem for sleep disturbances in patients with cirrhosis.

METHODS:

Fifty-two Child-Turcotte-Pugh (CTP) class A or B cirrhotics with Pittsburgh Sleep Quality Index >5 were randomized to either zolpidem 5 mg daily (n=26) or placebo (n=26) for 4 weeks.

RESULTS:

The therapy of 4 weeks was completed by 23 patients receiving zolpidem (3 stopped treatment due to excessive daytime drowsiness) and 24 receiving placebo (2 refused to continue the study). In the zolpidem group, after 4 weeks of therapy, there was significant increase in total sleep time (TST) and sleep efficiency compared to baseline and improvement in polysomnographic parameters of sleep initiation and maintenance (i.e., decrease in sleep latency time, decrease in wake time, and decreases in number of arousals and periodic limbs movements per hour of sleep), without any significant change in sleep architecture.

CONCLUSION:

Four weeks of 5 mg daily zolpidem in CTP class A or B cirrhosis patients with insomnia led to significant increases in TST and sleep efficiency and improvement in polysomnographic parameters of sleep initiation and maintenance without any significant change in sleep architecture.

KEYWORDS:

Cirrhosis; Insomnia; Sleep; Zolpidem

Supplemental Content

Full text links

Icon for Publishing M2Community Icon for PubMed Central
Loading ...
Support Center